Aspergillus mycotoxins and their effect on the host

References

• Tabata S. General aspects of mycotoxin. Mycotoxin, Y Hosogai, M Matsumoto. Chuo Hoki, Tokyo 2002; 71
   Google Scholar
• Fung F, Clark R. Health effects of mycotoxins: a toxicological overview. J Toxicol Clin Toxicol 2004; 42: 217–234
   PubMed Web of Science ®Google Scholar
• Rossano F, Ortega De Luna L, Buommino E, et al. Secondary metabolites of Aspergillus exert immunobiological effects on human monocytes. Res Microbiol 1999; 150: 13–19
   PubMed Web of Science ®Google Scholar
• Moon E, Pyo S. Aflatoxin B(1) inhibits CD14-mediated nitric oxide production in murine peritoneal macrophages. Int J Immunopharmacol 2000; 22: 237–246
   PubMed Web of Science ®Google Scholar
• Palanee T, Dutton M, Chuturgoon A. Cytotoxicity of aflatoxin B1 and its chemically synthesised epoxide derivative on the A549 human epithelioid lung cell line. Mycopathologia 2001; 151: 155–159
   PubMed Web of Science ®Google Scholar
• Bondy G, Pestka J. Immunomodulation by fungal toxins. J Toxicol Environmental Health Part B: Critical Reviews 2000; 3: 109–143
   PubMed Web of Science ®Google Scholar
• Tomee J, Kauffman H. Putative virulence factors of Aspergillus fumigatus. Clin Exp Allergy 2000; 30: 476–484
   Google Scholar
• Lioi M, Santoro A, Barbieri R, Salzano S, Ursini M. Ochratoxin A and zearalenone: a comparative study on genotoxic effects and cell death induced in bovine lymphocytes. Mutat Res 2004; 557: 19–27
   PubMed Web of Science ®Google Scholar
• Muller G, Rosner H, Rohrmann B, et al. Effects of the mycotoxin ochratoxin A and some of its metabolites on the human cell line THP-1. Toxicology 2003; 184: 69–82
   PubMed Web of Science ®Google Scholar
• Muller G, Burkert B, Moller U, et al. Ochratoxin A and some of its derivatives modulate radical formation of porcine blood monocytes and granulocytes. Toxicology 2004; 199: 251–259
   PubMed Web of Science ®Google Scholar
• Amitani R, Taylor G, Elezis E, et al. Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium. Infect Immun 1995; 63: 3266–3271
   PubMed Web of Science ®Google Scholar
• Kumagai T, Nagata T, Kudo Y, et al. Cytotoxic activity and cytokine gene induction of Asp-hemolysin to murine macrophages. Nippon Ishinkin Gakkai Zasshi 1999; 40: 217–222
   Google Scholar
• Kumagai T, Nagata T, Kudo Y, et al. Cytotoxic activity and cytokine gene induction of Asp-hemolysin to vascular endothelial cells. Yakugaku Zasshi 2001; 121: 271–275
   PubMedGoogle Scholar
• Mullbacher A, Waring P, Eichner R. Identification of an agent in cultures of Aspergillus fumigatus displaying anti-phagocytic and immunomodulating activity in vitro. J Gen Microbiol 1985; 131: 1251–1258
   PubMedGoogle Scholar
• Kobayashi M, Mullbacher A, Waring P, Hapel A. Gliotoxin treatment selectively spares M-CSF- plus IL-3-responsive multipotent haemopoietic progenitor cells in bone marrow. Eur J Haematol 1991; 46: 205–211
   Google Scholar
• Sutton P, Beaver J, Waring P. Evidence that gliotoxin enhances lymphocyte activation and induces apoptosis by effect on cyclic AMP levels. Biochem Pharmacol 1995; 50: 9–14
   Google Scholar
• Shah D, Jackman S, Engle J, Larsen B. Effect of gliotoxin on human polymorphonuclear neutrophils. Infect Dis Obst Gynecol 1998; 6: 168–175
   PubMedGoogle Scholar
• Wichmann G, Herbarth O, Lehmann I. The mycotoxins citrinin, gliotoxin, and patulin affect interferon-gamma rather than interleukin-4 production in human blood cells. Environ Toxicol 2002; 17: 211–218
   PubMed Web of Science ®Google Scholar
• Yamada A, Kataoka T, Nagai K. The fungal metabolite gliotoxin: immunosuppressive activity on CTL-mediated cytotoxicity. Immunol Lett 2000; 71: 27–32
   PubMed Web of Science ®Google Scholar
• Nieminen SM, Karki R, Auriola S, et al. Isolation and identification of Aspergillus fumigatus mycotoxins on growth medium and some building materials. Appl Environ Microbiol 2002; 68: 4871–4875
   PubMed Web of Science ®Google Scholar
• Suen Y, Fung K, Lee C, Kong S. Gliotoxin induces apoptosis in cultured macrophages via production of reactive oxygen species and cytochrome c release without mitochondrial depolarization. Free Radic Res 2001; 35: 1–10
   PubMed Web of Science ®Google Scholar
• Calvo A, Wilson R, Bok J, Keller N. Relationship between secondary metabolism and fungal development. Microbiol Mol Biol Rev 2002; 66: 447–459
   PubMed Web of Science ®Google Scholar
• Belkacemi L, Barton R, Hopwood V, Evans E. Determination of optimum growth conditions for gliotoxin production by Aspergillus fumigatus and development of a novel method for gliotoxin detection. J Med Vet Mycol 1999; 37: 227–233
   Google Scholar
• Kamei K, Watanabe A, Nishimura K, Miyaji M. Culture filtrate of Aspergillus fumigatus and its cytotoxic activity against leukocytes. Nippon Ishinkin Gakkai Zasshi 2002; 43: 163–166
   Google Scholar
• Watanabe A, Kamei K, Sekine T, et al. Immunosuppressive substances in Aspergillus fumigatus culture filtrate. J Infect Chemother 2003; 9: 114–121
   PubMedGoogle Scholar
• Watanabe A, Kamei K, Sekine T, et al. Cytotoxic substances from Aspergillus fumigatus in oxygenated or poorly oxygenated environment. Mycopathologia 2004; 158: 1–7
   Google Scholar
• Watanabe A, Kamei K, Sekine T, et al. Effect of aeration on gliotoxin production by Aspergillus fumigatus in its culture filtrate. Mycopathologia 2004; 157: 245–254
   Google Scholar
• Mitchell CG, Slight J, Donaldson K. Diffusible component from the spore surface of the fungus Aspergillus fumigatus which inhibits the macrophage oxidative burst is distinct from gliotoxin and other hyphal toxins. Thorax 1997; 52: 796–801
   PubMed Web of Science ®Google Scholar
• Hobson R. The effects of diffusates from the spores of Aspergillus fumigatus and A. terreus on human neutrophils, Naegleria gruberi, and Acanthamoeba castellani. Med Mycol 2000; 38: 133–141
   PubMedGoogle Scholar
• Speth C, Rambach G, Lass-Floerl C, et al. Culture supernatants of patient-derived Aspergillus isolates have toxic and lytic activity towards neurons and glia cells. FEMS Immunol Med Microbiol 2000; 29: 303–313
   Google Scholar
• Bertout S. Spore diffusate isolated from some strains of Aspergillus fumigatus inhibits phagocytosis by murine alveolar macrophages. FEMS Immunol Med Microbiol 2002; 33: 101–106
   PubMedGoogle Scholar
• Creppy E, Chiarappa P, Baudrimont I, et al. Synergistic effects of fumonisin B1 and ochratoxin A: are in vitro cytotoxicity data predictive of in vivo acute toxicity?. Toxicology 2004; 201: 115–123
   PubMed Web of Science ®Google Scholar
• Lamy B, Moutaouakil M, Latgé J, Davies J. Secretion of a potential virulence factor, a fungal ribonucleotoxin, during human aspergillosis infections. Mol Microbiol 1991; 5: 1811–1815
   PubMed Web of Science ®Google Scholar
• Bouchara J, Tronchin G, Larcher G, Chabasse D. The search for virulence determinants in Aspergillus fumigatus. Trends Microbiol 1995; 3: 327–330
   PubMedGoogle Scholar
• Smith J. Construction and pathogenicity of Aspergillus fumigatus mutants that do not produce the ribotoxin restrictocin. Mol Microbiol 1993; 9: 1071–1077
   Google Scholar
• Smith J, Tang C, Van Noorden S, Holden D. Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis. Infect Immun 1994; 62: 5247–5254
   PubMed Web of Science ®Google Scholar
• Fox M, Gray G, Kavanagh K, Lewis C, Doyle S. Detection of Aspergillus fumigatus mycotoxins: immunogen synthesis and immunoassay development. J Microbiol Methods 2004; 56: 221–230
   Google Scholar
• Bauer, F. Isolation of a mycotoxin (gliotoxin) from a bovine udder infected with Aspergillus fumigatus. J Med Vet Mycol 1989;27:45–50.
   PubMedGoogle Scholar
• Richard J, DeBey M. Production of gliotoxin during the pathogenic state in turkey poults by Aspergillus fumigatus Fresenius. Mycopath 1995; 129: 111–115
   Google Scholar
• Reeves E, Messina C, Doyle S, Kavanagh K. Correlation between gliotoxin production and virulence of Aspergillus fumigatus in Galleria mellonella. Mycopathologia 2004; 158: 73–79
   PubMed Web of Science ®Google Scholar
• Lewis, R, Wiederhold, N, Chi, J,, et al. Detection of gliotoxin in experimental and human aspergillosis. Infect Immun, in press;
   Google Scholar
• Sutton P. Exacerbation of invasive aspergillosis by the immunosuppresive fungal metabolite, gliotoxin. Immunol Cell Biol 1996; 74: 318–322
   PubMed Web of Science ®Google Scholar
• Bok J, Keller N. LaeA, a regulator of secondary metabolism in Aspergillus spp. Eukaryot Cell 2004; 3: 527–535
   PubMed Web of Science ®Google Scholar
• Yabe K, Nakajima H. Enzyme reactions and genes in aflatoxin biosynthesis. Appl Microbiol Biotechnol 2004; 64: 745–755
   PubMed Web of Science ®Google Scholar
• Latge J. The pathobiology of Aspergillus fumigatus. Trends Microbiol 2001; 9: 382–389
   PubMed Web of Science ®Google Scholar
• Reeves E, Murphy T, Daly P, Kavanagh K. Amphotericin B enhances the synthesis and release of the immunosuppressive agent gliotoxin from the pulmonary pathogen Aspergillus fumigatus. J Med Microbiol 2004; 53: 719–725
   PubMed Web of Science ®Google Scholar